Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-17

Clinical Trial Update: Dextromethorphan in Treating Patients With Fatigue Caused by Cancer [NA]

View source ↗

Summary

A clinical trial evaluating dextromethorphan for cancer-related fatigue was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: TERMINATED